Overview

Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Assessment of the interaction of tipranavir/ritonavir (TPV/RTV) and valaciclovir (VAL), a prodrug of aciclovir (ACV)
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Acyclovir
Ritonavir
Tipranavir
Valacyclovir